COGT, Technical entry , low float

Unum Therapeutics Inc., a biopharmaceutical company, focuses on developing a pipeline of novel therapies to treat cancer patients.

This is a technical based entry , product is ranging so I will set my target at a realistic resistance area .

I do like some of their fundamental metrics too. Primarily their eps which is expected to grow throughout the next two years and the recent institutional interest. Also, shares outstanding is only 9.85 Million so with some buying volume this certainly has the ability to move up quickly . Nonetheless, this is ranging and it's a technical based swing play only at this time for me .

Good luck ~